Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Stranzl

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Immunogenetics|April 10, 2010
NetCTLpan: pan-specific MHC class I pathway epitope predictionsThomas Stranzl, Mette Voldby Larsen, Claus Lundegaard, et al.
Analytical Chemistry|July 12, 2013
Optimized nonlinear gradients for reversed-phase liquid chromatography in shotgun proteomicsLuminita Moruz, Peter Pichler, Thomas Stranzl, et al.
Plos One|October 11, 2012
The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope densityThomas Stranzl, Mette V Larsen, Ole Lund, et al.
Journal of Proteome Research|June 10, 2014
MS Amanda, a universal identification algorithm optimized for high accuracy tandem mass spectraViktoria Dorfer, Peter Pichler, Thomas Stranzl, et al.
Journal of Proteome Research|November 5, 2015
Comprehensive Cross-Linking Mass Spectrometry Reveals Parallel Orientation and Flexible Conformations of Plant HOP2-MND1Evelyn Rampler, Thomas Stranzl, Zsuzsanna Orban-Nemeth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphomaMartin Filipits, Ulrich Jaeger, Gudrun Pohl, et al.
Allergy|January 29, 2020
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III studyThomas Stranzl, Henrik Ipsen, Lars Harder Christensen, et al.
Allergy|April 11, 2021
Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy"Thomas Stranzl, Henrik Ipsen, Lars Harder Christensen, et al.
Journal of Proteome Research|April 5, 2016
Correction to "Comprehensive Cross-Linking Mass Spectrometry Reveals Parallel Orientation and Flexible Conformations of Plant HOP2-MND1"Evelyn Rampler, Thomas Stranzl, Zsuzsanna Orban-Nemeth, et al.
Breast Cancer Research and Treatment|October 24, 2003
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapyMargaretha Rudas, Martin Filipits, Susanne Taucher, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Immunogenetics|April 10, 2010
NetCTLpan: pan-specific MHC class I pathway epitope predictionsThomas Stranzl, Mette Voldby Larsen, Claus Lundegaard, et al.
Analytical Chemistry|July 12, 2013
Optimized nonlinear gradients for reversed-phase liquid chromatography in shotgun proteomicsLuminita Moruz, Peter Pichler, Thomas Stranzl, et al.
Plos One|October 11, 2012
The cancer exome generated by alternative mRNA splicing dilutes predicted HLA class I epitope densityThomas Stranzl, Mette V Larsen, Ole Lund, et al.
Journal of Proteome Research|June 10, 2014
MS Amanda, a universal identification algorithm optimized for high accuracy tandem mass spectraViktoria Dorfer, Peter Pichler, Thomas Stranzl, et al.
Journal of Proteome Research|November 5, 2015
Comprehensive Cross-Linking Mass Spectrometry Reveals Parallel Orientation and Flexible Conformations of Plant HOP2-MND1Evelyn Rampler, Thomas Stranzl, Zsuzsanna Orban-Nemeth, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2002
Cyclin D3 is a predictive and prognostic factor in diffuse large B-cell lymphomaMartin Filipits, Ulrich Jaeger, Gudrun Pohl, et al.
Allergy|January 29, 2020
Limited impact of Der p 23 IgE on treatment outcomes in tablet allergy immunotherapy phase III studyThomas Stranzl, Henrik Ipsen, Lars Harder Christensen, et al.
Allergy|April 11, 2021
Reply to "Inferring clinical relevance of der p 23 from the restricted effect on treatment outcomes after tablet allergy immunotherapy"Thomas Stranzl, Henrik Ipsen, Lars Harder Christensen, et al.
Journal of Proteome Research|April 5, 2016
Correction to "Comprehensive Cross-Linking Mass Spectrometry Reveals Parallel Orientation and Flexible Conformations of Plant HOP2-MND1"Evelyn Rampler, Thomas Stranzl, Zsuzsanna Orban-Nemeth, et al.
Breast Cancer Research and Treatment|October 24, 2003
Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapyMargaretha Rudas, Martin Filipits, Susanne Taucher, et al.
Pageof 3